2011
DOI: 10.1111/j.1445-5994.2011.02554.x
|View full text |Cite
|
Sign up to set email alerts
|

Using computed tomography coronary angiography to evaluate patients with acute chest pain: putting the horse before the cart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2012
2012
2014
2014

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…Examples of premature adoption of new technologies include endovascular intervention in acute stroke, 34 use of CT coronary angiography 35 and high-sensitivity cardiac troponin assays 36 in assessment of acute chest pain and renal denervation in treatment-resistant hypertension. 37 Another problem is 'indication creep', whereby proof-of-benefit in selected patient groups is extrapolated uncritically to a wider spectrum of patients.…”
Section: Defer the Use Of Unproven Interventionsmentioning
confidence: 99%
“…Examples of premature adoption of new technologies include endovascular intervention in acute stroke, 34 use of CT coronary angiography 35 and high-sensitivity cardiac troponin assays 36 in assessment of acute chest pain and renal denervation in treatment-resistant hypertension. 37 Another problem is 'indication creep', whereby proof-of-benefit in selected patient groups is extrapolated uncritically to a wider spectrum of patients.…”
Section: Defer the Use Of Unproven Interventionsmentioning
confidence: 99%
“…The recent Medicare reimbursement of coronary computed tomographic angiography (CCTA) reflects the potential of this technology to result in significant cost‐savings and improved management of patients with coronary artery disease, including those presenting to the emergency department (ED) with chest pain. In his recent editorial, Scott 1 expresses concerns that CCTA is a ‘new test with possible unchartered hazards’, and implies that the use of CCTA in evaluating acute chest pain is a premature application of this technology.…”
mentioning
confidence: 99%